We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGN
276
DELISTED
Immunogen Inc
IMGN
$8.44M 0.06%
2,389,296
-300,000
-11% -$1.28M
HRB icon
277
H&R Block
HRB
$5.98B
$8.39M 0.06%
258,483
+4,860
+2% +$180K
LRCX icon
278
Lam Research
LRCX
$316B
$8.34M 0.06%
170,940
-2,750
-2% -$135K
MSCI icon
279
MSCI
MSCI
$42.4B
$8.27M 0.06%
16,062
-16,610
-51% -$8.79M
ORCL icon
280
Oracle
ORCL
$339B
$8.27M 0.06%
96,653
+7,245
+8% +$635K
BNY
281
Bank of New York Mellon
BNY
$103B
$8.22M 0.06%
196,494
+61,341
+45% +$2.97M
KFY icon
282
Korn Ferry
KFY
$4.31B
$8.16M 0.06%
171,419
+76,199
+80% +$4.11M
AMP icon
283
Ameriprise Financial
AMP
$47.8B
$8.16M 0.06%
28,931
+18,987
+191% +$6.22M
TRU icon
284
TransUnion
TRU
$16B
$8.11M 0.06%
141,846
-65,278
-32% -$4.27M
CWEN icon
285
Clearway Energy Class C
CWEN
$4.79B
$8.08M 0.06%
+280,247
New +$9M
T icon
286
AT&T
T
$164B
$8.06M 0.06%
454,660
+38,149
+9% +$729K
HOG icon
287
Harley-Davidson
HOG
$2.61B
$8.02M 0.06%
229,419
+60,232
+36% +$2.65M
WFG icon
288
West Fraser Timber
WFG
$5.21B
$7.99M 0.06%
121,864
-26,256
-18% -$2.02M
MMM icon
289
3M
MMM
$91.8B
$7.96M 0.06%
98,430
-179,414
-65% -$16.9M
STRO icon
290
Sutro Biopharma
STRO
$386M
$7.91M 0.05%
186,078
+107,160
+136% +$6.8M
ZBH icon
291
Zimmer Biomet
ZBH
$18.8B
$7.89M 0.05%
66,339
+3,748
+6% +$471K
NUVL
292
DELISTED
Nuvalent
NUVL
$7.78M 0.05%
323,851
+65,202
+25% +$1.93M
TSCO icon
293
Tractor Supply
TSCO
$16.3B
$7.7M 0.05%
177,945
+43,185
+32% +$1.97M
IT icon
294
Gartner
IT
$11.1B
$7.67M 0.05%
25,576
+10,494
+70% +$3.47M
SPLK
295
DELISTED
Splunk Inc
SPLK
$7.59M 0.05%
86,042
+64,718
+303% +$6.2M
DNLI icon
296
Denali Therapeutics
DNLI
$3.79B
$7.59M 0.05%
357,878
LH icon
297
Labcorp
LH
$25.2B
$7.56M 0.05%
41,683
-15,360
-27% -$3.16M
NRIX icon
298
Nurix Therapeutics
NRIX
$2.45B
$7.36M 0.05%
900,088
+49,513
+6% +$516K
CERE
299
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$7.35M 0.05%
327,221
PRU icon
300
Prudential Financial
PRU
$42.6B
$7.34M 0.05%
96,369
+35,325
+58% +$3.37M

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.